Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults

This study has been completed.
Eli Lilly and Company
Information provided by (Responsible Party):
Melissa Delbello, University of Cincinnati Identifier:
First received: February 16, 2009
Last updated: August 3, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)